56 research outputs found
Pengaruh Inflasi, PDRB dan Upah Minimum terhadap Penyerapan Tenaga Kerja di Provinsi Bali
Population growth in the country of Indonesia progressively increasing in number, as well as population growth in the province of Bali. Population growth will certainly add to the amount of labor. Increasing the number of workers will be a problem in the world of employment if the amount of labor is not proportional to the number of jobs that can absorb them. This problem becomes important considering the close relation to unemployment. High unemployment will increase the probability of poverty, crime, and social phenomena in society-economy. Bali provincial tourism potential it still has a considerable amount of unemployment. This study has the aim to find out how the influence of the three factors which in theory have an impact on employment. The third factor in the Province of Bali is inflation, Gross Domestic Product (GDP) and the minimum wage. The data used are time series data for twenty years from 1994 until 2013.”The data analysis technique used is multiple linear regression with EViews application. Once testing is done, the results obtained are simultaneous, three independent variables tested had a significant effect, while partial, Gross Domestic Product (GDP) and the minimum wage has a positive and significant influence while inflation has a negative and significant effect on employment in Bali Province year period 1994-2013”
Pencegahan Risiko Jatuh Pada Lanjut Usia Melalui Latihan Rentang Gerak
Jatuh merupakan penyebab terjadinya injury sehingga penderita harus masuk ke rumah sakit. Penurunan fungsi system muskuloskeletal pada lanjut usia merupakan bagian dari faktor risiko intrinsic yang menyebabkan lanjut usia mudah untuk jatuh. Latihan rentang gerak akan meningkatkan flexibilitas sendi dan kontraksi otot. Tujuan kegiatan pengabdian masyarakat ini adalah sebagai upaya pencegahan risiko jatuh pada lanjut usia melalui demonstrasi latihan rentang gerak . Sasaran khalayak dari pengabdian masyarakat ini adalah para lanjut usia di panti werdha taman bodhi asri Medan. Pelaksanaan pengabdian masyarakat ini dilakukan pada bulan juni 2023 dengan kegiatan latihan rentang gerak pada persendian leher, bahu, siku, pergelangan tangan, jari tangan, dan pergelangan kaki. Hasil: Penilaian yang di dapat dari latihan rentang gerak ini pada setiap lanjut usia sangatlah bervariasi. Kesimpulan: Kegiatan ini mendapatkan respon positive, dimana para lansia terlibat dalam latihan ini. Latihan yang dilakukan secara berulang-ulang dan terus menerus akan meningkatkan flexibilitas sendi dan kekuatan otot sehingga menurunkan faktor risiko intrisik terjadinya jatuh pada lanjut usia. Disarankan agar sebelum dan setelah melakukan latihan rentang gerak perlu di monitor tanda-tanda vitalnya oleh karena aktivitas dapat berdampak kepada perubahan tanda-tanda vital lanjut usia
Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.
INTRODUCTION: There are few data regarding the tolerability, safety, or efficacy of antenatal atazanavir. We report our clinical experience of atazanavir use in pregnancy.
METHODS: A retrospective medical records review of atazanavir-exposed pregnancies in 12 London centres between 2004 and 2010.
RESULTS: There were 145 pregnancies in 135 women: 89 conceived whilst taking atazanavir-based combination antiretroviral therapy (cART), "preconception" atazanavir exposure; 27 started atazanavir-based cART as "first-line" during the pregnancy; and 29 "switched" to an atazanavir-based regimen from another cART regimen during pregnancy. Gastrointestinal intolerance requiring atazanavir cessation occurred in five pregnancies. Self-limiting, new-onset transaminitis was most common in first-line use, occurring in 11.0%. Atazanavir was commenced in five switch pregnancies in the presence of transaminitis, two of which discontinued atazanavir with persistent transaminitis. HIV-VL < 50 copies/mL was achieved in 89.3% preconception, 56.5% first-line, and 72.0% switch exposures. Singleton preterm delivery (<37 weeks) occurred in 11.7% preconception, 9.1% first-line, and 7.7% switch exposures. Four infants required phototherapy. There was one mother-to-child transmission in a poorly adherent woman.
CONCLUSIONS: These data suggest that atazanavir is well tolerated and can be safely prescribed as a component of combination antiretroviral therapy in pregnancy
Novel insights into breast cancer genetic variance through RNA sequencing
Using RNA sequencing of triple-negative breast cancer (TNBC), non-TBNC and HER2-positive breast cancer sub-types, here we report novel expressed variants, allelic prevalence and abundance, and coexpression with other variation, and splicing signatures. To reveal the most prevalent variant alleles, we overlaid our findings with cancer- and population-based datasets and validated a subset of novel variants of cancer-related genes: ESRP2, GBP1, TPP1, MAD2L1BP, GLUD2 and SLC30A8. As a proof-of-principle, we demonstrated that a rare substitution in the splicing coordinator ESRP2(R353Q) impairs its ability to bind to its substrate FGFR2 pre-mRNA. In addition, we describe novel SNPs and INDELs in cancer relevant genes with no prior reported association of point mutations with cancer, such as MTAP and MAGED1. For the first time, this study illustrates the power of RNA-sequencing in revealing the variation landscape of breast transcriptome and exemplifies analytical strategies to search regulatory interactions among cancer relevant molecules
Recommended from our members
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy
Purpose
To determine the time and risk factors for developing proliferative diabetic retinopathy (PDR) and vitreous hemorrhage (VH).
Design
Multicenter, national cohort study.
Methods
Anonymized data of 50 254 patient eyes with diabetes mellitus at 19 UK hospital eye services were extracted at the initial and follow-up visits between 2007 and 2014. Time to progression of PDR and VH were calculated with Cox regression after stratifying by baseline diabetic retinopathy (DR) severity and adjusting for age, sex, race, and starting visual acuity.
Results
Progression to PDR in 5 years differed by baseline DR: no DR (2.2%), mild (13.0%), moderate (27.2%), severe nonproliferative diabetic retinopathy (NPDR) (45.5%). Similarly, 5-year progression to VH varied by baseline DR: no DR (1.1%), mild (2.9%), moderate (7.3%), severe NPDR (9.8%). Compared with no DR, the patient eyes that presented with mild, moderate, and severe NPDR were 6.71, 14.80, and 28.19 times more likely to develop PDR, respectively. In comparison to no DR, the eyes with mild, moderate, and severe NPDR were 2.56, 5.60, and 7.29 times more likely to develop VH, respectively. In severe NPDR, the eyes with intraretinal microvascular abnormalities (IRMA) had a significantly increased hazard ratio (HR) of developing PDR (HR 1.77, 95% confidence interval [CI] 1.25–2.49, P = .0013) compared with those with venous beading, whereas those with 4-quadrant dot-blot hemorrhages (4Q DBH) had 3.84 higher HR of developing VH (95% CI 1.39–10.62, P = .0095).
Conclusions
Baseline severities and features of initial DR are prognostic for PDR development. IRMA increases risk of PDR whereas 4Q DBH increases risk of VH
Recommended from our members
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema
Aims: To describe baseline characteristics and visual outcome for eyes treated with ranibizumab for diabetic macular oedema (DMO) from a multicentre database.
Methods: Structured clinical data were anonymised and extracted from an electronic medical record from 19 participating UK centres: age at first injection, ETDRS visual acuity (VA), number of injections, ETDRS diabetic retinopathy (DR) and maculopathy grade at baseline and visits. The main outcomes were change in mean VA from baseline, number of injections and clinic visits and characteristics affecting VA change and DR grade.
Results: Data from 12 989 clinic visits was collated from baseline and follow-up for 3103 eyes. Mean age at first treatment was 66 years. Mean VA (letters) for eyes followed at least 2 years was 51.1 (SD=19.3) at baseline, 54.2 (SD: 18.6) and 52.5 (SD: 19.4) at 1 and 2 years, respectively. Mean visual gain was five letters. The proportion of eyes with VA of 72 letters or better was 25% (baseline) and 33% (1 year) for treatment naïve eyes. Eyes followed for at least 6 months received a mean of 3.3 injections over a mean of 6.9 outpatient visits in 1 year.
Conclusions: In a large cohort of eyes with DMO treated with ranibizumab injections in the UK, 33% of patients achieved better than or equal to 6/12 in the treated eye at 12 months compared with 25% at baseline. The mean visual gain was five letters. Eyes with excellent VA at baseline maintain good vision at 18 months
Visual Acuity Improvement When Switching From Ranibizumab To Aflibercept Is Not Sustained
PURPOSE: To assess whether visual benefits exist in switching to aflibercept in patients who have been chronically treated with ranibizumab for neovascular age-related macular degeneration. METHODS: A multicenter, national, electronic medical record database study was performed. Patients undergoing six continuous monthly ranibizumab injections and then switched to continuous aflibercept were matched to those on continuous ranibizumab therapy. Matching was performed in a 2:1 ratio and based on visual acuity 6 months before and at the time of the switch, and the number of previous ranibizumab injections. RESULTS: Patients who were switched to aflibercept demonstrated transiently significant improvement in visual acuity that peaked at an increase of 0.9 Early Treatment Diabetic Retinopathy Study letters 3 months after the switch, whereas control patients continued on ranibizumab treatment showed a steady decline in visual acuity. Visual acuity differences between the groups were significant (P < 0.05) at 2, 3, and 5 months after the switch. Beginning at 4 months after the switch, the switch group showed a visual acuity decline similar to the control group. CONCLUSION: Transient, nonsustained improvement in visual acuity occurs when switching between anti-vascular endothelial growth factor agents, which may have implications in treating patients on chronic maintenance therapy on one anti-vascular endothelial growth factor medication
Similarities in the packaging of cyanoacrylate nail glue and ophthalmic preparations: an ongoing problem
- …